Ascendis Pharma AS (A71)

Frankfurt
Currency in EUR
140.00
0.00(0.00%)
Delayed Data·
A71 Scorecard
Full Analysis
Impressive gross profit margins
Fair Value
Day's Range
140.00140.00
52 wk Range
99.00155.00
Key Statistics
Edit
Bid/Ask
144.00 / 146.00
Prev. Close
132
Open
140
Day's Range
140-140
52 wk Range
99-155
Volume
-
Average Volume (3m)
14
1-Year Change
5.26%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
A71 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Ascendis Pharma AS Company Profile

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It also develops a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. Ascendis Pharma A/S was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Employees
1017
Market
Germany

Compare A71 to Peers and Sector

Metrics to compare
A71
Peers
Sector
Relationship
P/E Ratio
−22.0x−1.4x−0.5x
PEG Ratio
−0.970.020.00
Price/Book
−78.6x1.0x2.6x
Price / LTM Sales
22.8x7.3x2.9x
Upside (Analyst Target)
-197.2%66.2%
Fair Value Upside
Unlock8.6%10.3%Unlock

Earnings

Latest Release
Feb 12, 2025
EPS / Forecast
-0.64 / -0.98
Revenue / Forecast
173.92M / 119.46M
EPS Revisions
Last 90 days

People Also Watch

72.65
INSM
+3.49%
49.70
BN
+1.78%
58.920
VRNA
+1.06%
26.78
SLM
+1.90%
33.080
YPF
+1.82%

FAQ

What Is the Ascendis Pharma AS (A71) Stock Price Today?

The Ascendis Pharma AS stock price today is 140.00

What Stock Exchange Does Ascendis Pharma AS Trade On?

Ascendis Pharma AS is listed and trades on the Frankfurt stock exchange.

What Is the Stock Symbol for Ascendis Pharma AS?

The stock symbol for Ascendis Pharma AS is "A71."

What Is the Ascendis Pharma AS Market Cap?

As of today, Ascendis Pharma AS market cap is 8.69B.

What is Ascendis Pharma AS Earnings Per Share?

The Ascendis Pharma AS EPS is -6.53.

What Is the Next Ascendis Pharma AS Earnings Date?

Ascendis Pharma AS will release its next earnings report on May 20, 2025.

From a Technical Analysis Perspective, Is A71 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.